Parexel principles for artificial intelligence (AI)
Parexel is committed to the development of innovative, high-value, high-quality use cases for AI. We believe AI provides tools to help manage the increasing complexity of clinical development, including opportunities to expedite development timelines for products to reach patients quicker.
Here we outline our six principles for how Parexel conceives, develops, deploys, and monitors AI applications intended for use in clinical development and throughout our business.
Related Insights
Blog
Using ethical AI to streamline HEOR
Jan 26, 2024
Blog
Generative AI and how we can harness its power in clinical development
Sep 26, 2023
Blog
Putting AI to work in your safety program
May 21, 2021
Article
Human-in-the loop AI: a proven approach to streamlining PV case processing and review
Oct 7, 2024
Article
Delivering AI-managed clinical research data: Parexel’s end-to-end automation strategy
Mar 11, 2025
Blog
Regulatory acceptability of AI: Current perspectives
Mar 7, 2024
Video
Insights with Goldman Sachs Part 5: Pioneering new approaches, technologies, and AI to drive innovation
Jan 26, 2024
Blog
Clinical pharmacology, modeling and simulation to support FIH study design
Oct 21, 2021
Blog
Actigraphy advances a patient-first approach: Reduce patient burden — and make the most of valuable data
Oct 15, 2021
Blog
Capitalizing on sensors in clinical trials
Sep 20, 2021
Blog
Highlights from ISMPP Asia Pacific Meeting 2021
Sep 20, 2021
Whitepaper
AI-powered pharmacovigilance: From reactive reporting to predictive risk
Mar 24, 2025
Related Insights
Blog
Using ethical AI to streamline HEOR
Jan 26, 2024
Blog
Generative AI and how we can harness its power in clinical development
Sep 26, 2023
Blog
Putting AI to work in your safety program
May 21, 2021
Article
Human-in-the loop AI: a proven approach to streamlining PV case processing and review
Oct 7, 2024
Article
Delivering AI-managed clinical research data: Parexel’s end-to-end automation strategy
Mar 11, 2025
Blog
Regulatory acceptability of AI: Current perspectives
Mar 7, 2024
Video
Insights with Goldman Sachs Part 5: Pioneering new approaches, technologies, and AI to drive innovation
Jan 26, 2024
Blog
Clinical pharmacology, modeling and simulation to support FIH study design
Oct 21, 2021
Blog
Actigraphy advances a patient-first approach: Reduce patient burden — and make the most of valuable data
Oct 15, 2021
Blog
Capitalizing on sensors in clinical trials
Sep 20, 2021
Blog
Highlights from ISMPP Asia Pacific Meeting 2021
Sep 20, 2021
Whitepaper
AI-powered pharmacovigilance: From reactive reporting to predictive risk
Mar 24, 2025